<DOC>
	<DOCNO>NCT00312754</DOCNO>
	<brief_summary>The purpose clinical research study learn BMS-232632 administer Atazanavir/ritonavir ( ATV/RTV ) superior anti-retroviral regimen include Lopinavir/ritonavir ( LPV/RTV ) , assess increase brachial artery flow-mediated vasodilatation ( FMD ) , HIV-infected patient . The safety treatment also study .</brief_summary>
	<brief_title>A Phase IV Study BMS-232632 HIV+ Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Documented Metabolic Syndrome least 3 follow parameter : Abdominal obesity , assessed waist circumference ( men &gt; 103 cm , woman &gt; 88 cm ) . Triglycerides &gt; 150 mg/dl . HDL cholestrol ( men &lt; 40 mg/dl , woman &lt; 50 mg/dl ) . Blood pressure &gt; equal 130/85 mm Hg . Fasting serum glucose &gt; equal 110 mg/dl . HIV RNA &lt; 50 copies/mL . IP within 3 month prior selection . Treated Metabolic Syndrom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>